- Home
- PBA vs STE Comparison
PBA vs STE Comparison
Compare PBA & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBA
- STE
- Stock Information
- Founded
- PBA 1997
- STE 1985
- Country
- PBA Canada
- STE United States
- Employees
- PBA N/A
- STE N/A
- Industry
- PBA Oil & Gas Production
- STE Industrial Specialties
- Sector
- PBA Energy
- STE Health Care
- Exchange
- PBA Nasdaq
- STE Nasdaq
- Market Cap
- PBA 24.0B
- STE 22.1B
- IPO Year
- PBA N/A
- STE 1992
- Fundamental
- Price
- PBA $36.89
- STE $208.68
- Analyst Decision
- PBA Buy
- STE Buy
- Analyst Count
- PBA 1
- STE 5
- Target Price
- PBA $57.00
- STE $262.50
- AVG Volume (30 Days)
- PBA 1.6M
- STE 565.1K
- Earning Date
- PBA 11-05-2024
- STE 02-05-2025
- Dividend Yield
- PBA 5.28%
- STE 1.09%
- EPS Growth
- PBA 51.43
- STE N/A
- EPS
- PBA 2.43
- STE 4.37
- Revenue
- PBA $7,305,229,650.00
- STE $5,325,525,000.00
- Revenue This Year
- PBA N/A
- STE $7.91
- Revenue Next Year
- PBA $15.54
- STE $6.37
- P/E Ratio
- PBA $15.61
- STE $35.07
- Revenue Growth
- PBA 37.18
- STE 15.75
- 52 Week Low
- PBA $32.81
- STE $197.82
- 52 Week High
- PBA $43.44
- STE $248.24
- Technical
- Relative Strength Index (RSI)
- PBA 30.56
- STE 40.49
- Support Level
- PBA $38.75
- STE $202.72
- Resistance Level
- PBA $39.39
- STE $208.56
- Average True Range (ATR)
- PBA 0.65
- STE 4.52
- MACD
- PBA -0.19
- STE -0.33
- Stochastic Oscillator
- PBA 23.92
- STE 35.95
About PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its assets include pipelines and gas gathering as well as assets across fractionation, storage, and propane exports.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.